UWorld Pharmacology Practice Test

The correct dietary modification to emphasize for a client prescribed a GLP-1 receptor agonist is lowered fat consumption. GLP-1 receptor agonists, which are used in the management of type 2 diabetes, help to regulate blood glucose levels and promote weight loss. These medications work by increasing insulin secretion, decreasing glucagon release, and slowing gastric emptying.

Reducing dietary fat is particularly important because high-fat meals can contribute to increased caloric intake and obesity, which may counteract the therapeutic effects of GLP-1 receptor agonists. Patients may also experience gastrointestinal side effects such as nausea and vomiting when they consume high-fat meals, which can be exacerbated by these medications. Therefore, focusing on lowering fat consumption can help mitigate these side effects and support weight management efforts.

In contrast, an emphasis on increased protein intake or carbohydrate intake may not directly help manage weight or enhance the effects of GLP-1 receptor agonists. A balanced caloric intake alone may not specifically target the need to reduce fat consumption, making it less relevant in this context. By prioritizing lower fat intake, clients can better align their dietary habits with the pharmacological benefits of GLP-1 receptor agonists.